FAUCI ARCHIVE — EMAIL THREAD: Heads up https://faucisdiary.com/correspondence/heads-up 1 message, Apr 10, 2010 Text below is verbatim from the released PDFs, with the original line breaks. ============================================================================== Subject: Fw: Heads up From: Michael Kurilla To: Anthony Fauci Sent: Sat, 10 Apr 2010 20:29:29 -0400 Source: Reading Room, pp. 483–495 of Reading-Room-FINAL.pdf ------------------------------------------------------------------------------ Tony, I'll add on on slide with 4 bullets summarizing the WH activity. Mike -------------------------- Sent from my BlackBerry Wireless Handheld. Please excuse my typing; I suffer from blackberry thumb syndrome. From: Collins, Francis (NIH/OD) [E] To: Fauci, Anthony (NIH/NIAID) [E] Cc: Hudson, Kathy (NIH/OD) [E]; Kurilla, Michael (NIH/NIAID) [E]; Heilman, Carole (NIH/NIAID) [E]; Conrad, Patricia (NIH/NIAID) [E]; Folkers, Greg (NIH/NIAID) [E]; Auchincloss, Hugh (NIH/NIAID) [E]; McGowan, John J. (NIH/NIAID) [E]; Wood, Gretchen (NIH/OD) [E]; Flowers, Susan (NIH/OD) [E] Sent: Sat Apr 10 17:15:09 2010 Subject: RE: Heads up Hi Tony, Thanks for this heads up. I would very much like to hear more about how this MCM initiative is shaping up. Perhaps Friday morning April 16 would work, but I am ccing Gretchen and Sus to encourage them to find the right time. Francis From: Fauci, Anthony (NIH/NIAID) [E] Sent: Saturday, April 10, 2010 11:27 AM To: Collins, Francis (NIH/OD) [E] Cc: Hudson, Kathy (NIH/OD) [E]; Kurilla, Michael (NIH/NIAID) [E]; Heilman, Carole (NIH/NIAID) [E]; Conrad, Patricia (NIH/NIAID) [E]; Folkers, Greg (NIH/NIAID) [E]; Auchincloss, Hugh (NIH/NIAID) [E]; McGowan, John J. (NIH/NIAID) [E] Subject: Heads up Francis: First, I hope that things have improved greatly with your daughter’s illness. Second, I want to give you a heads up that I have called your office to arrange for me to brief you on how things have been progressing with our weekly White House meetings with Heidi Avery of the National Security Staff (NSS). As you may know she is John Brennan’s Deputy and is intensively interested in “transforming” how we respond to deliberate and naturally occurring biological threats through the development of medical countermeasures (MCM). She has been making a number of proposals that have been discussed at length at these meetings and have undergone a continual series of modifications based on comments from the participants. The “Program” has now matured to the point of including 4 elements: 1) boosting regulatory science; 2) developing Transformational Centers of Excellence for Advanced Development and Manufacturing of MCM; 3) establishing an independent strategic investment firm (i.e. a government venture capital-like organization) for innovation in MCM; 4) and finally an idea that she got from what NIAID has been doing for some time on a relatively small scale – the development of a “concept exploitation focus” to help stimulate discovery and translation. What we have been doing is playing an active role from the time a grantee makes a discovery, but has no experience in pushing it into translation. NIAID has served as a “sherpa” or chaperone for the investigators by providing them with NIAID assets (reagents, animal models, connection to the regulatory process, etc.) to begin the process of translation. This is totally compatible with your interest in translational research on a broader scale including the CTSAs , particularly in light of the Cures Good afternoon Ms. Conrad As you know, Dr. Collins will be meeting with Dr. Fauci regarding Medical Countermeasures. You have been assigned the lead in preparing briefing information for this meeting. Please prepare the material for this meeting using the outline below and submit this material electronically to me as soon as possible. BACKGROUND INFORMATION Name of Meeting Date of Meeting Time ACTION REQUIRED BY THE DIRECTOR: PURPOSE OF MEETING (one sentence): BACKGROUND (short summary, 3-4 sentences): PARTICIPANTS: DISCUSSION POINTS/TALKING POINTS (using concise/to the point bullets): Attachments: • Bios • Relevant correspondence • Supplemental Information • Etc. Thank you, Nicholas DiCrosta Management Intern currently on rotation with the NIH Executive Secretariat BACKGROUND INFORMATION HHS/White House Medical Countermeasure Initiative (MCM) Briefing Friday, April 16, 2010 9:00 am – 10:00 am ACTION REQUIRED BY THE DIRECTOR: None PURPOSE OF MEETING: The purpose of the meeting is to brief you on NIAID’s role in the HHS/White House Medical Countermeasure (MCM) Initiative. BACKGROUND: NIAID has participated in weekly meetings with The White House (National Security Staff - NSS) and HHS staff to create a “transforming” initiative on how the US government responds to deliberate and naturally occurring biological threats through the development of medical countermeasures (MCM). NSS Staff will soon seek new money from OMB to support this new initiative. The “Program” includes 4 elements: 1) boosting regulatory science; 2) developing Transformational Centers of Excellence for Advanced Development and Manufacturing of MCM; 3) establishing an independent strategic investment firm (i.e. a government venture capital-like organization) for innovation in MCM; 4) the development of a “concept exploitation focus” to help stimulate discovery and translation. PARTICIPANTS: Anthony S. Fauci, MD, Director, NIAID Michael G Kurilla, MD-PhD Director, Office of BioDefense Research Affairs Associate Director for BioDefense Product Development , NIAID DISCUSSION POINTS/TALKING POINTS (using concise/to the point bullets): Attachments: • Bios • Relevant correspondence • Supplemental Information • Etc. Thank you, Nicholas DiCrosta Management Intern currently on rotation with the NIH Executive Secretariat Good afternoon Ms. Conrad As you know, Dr. Collins will be meeting with Dr. Fauci regarding Medical Countermeasures. You have been assigned the lead in preparing briefing information for this meeting. Please prepare the material for this meeting using the outline below and submit this material electronically to me as soon as possible. BACKGROUND INFORMATION Name of Meeting Date of Meeting Time ACTION REQUIRED BY THE DIRECTOR: PURPOSE OF MEETING (one sentence): BACKGROUND (short summary, 3-4 sentences): PARTICIPANTS: DISCUSSION POINTS/TALKING POINTS (using concise/to the point bullets): Attachments: • Bios • Relevant correspondence • Supplemental Information • Etc. Thank you, Nicholas DiCrosta Management Intern currently on rotation with the NIH Executive Secretariat BACKGROUND INFORMATION HHS/White House Medical Countermeasure Initiative (MCM) Briefing Friday, April 16, 2010 9:00 am – 10:00 am ACTION REQUIRED BY THE DIRECTOR: None PURPOSE OF MEETING: The purpose of the meeting is to brief NIH Director on NIAID’s role in the HHS/White House Medical Countermeasure (MCM) Initiative. BACKGROUND: NIAID has participated in weekly meetings with The White House (National Security Staff - NSS) and HHS staff to create a “transforming” initiative on how the US government responds to deliberate and naturally occurring biological threats through the development of medical countermeasures (MCM). The initiative was driven predominantly by Heidi Avery (Deputy to John Brennan) and NSS Staff who will soon seek new money from OMB to support this new initiative. The “Program” includes 4 elements: 1) boosting regulatory science; 2) developing Transformational Centers of Excellence for Advanced Development and Manufacturing of MCM; 3) establishing an independent strategic investment firm (i.e. a government venture capital-like organization) for innovation in MCM; 4) the development of a “concept exploitation focus” to help stimulate discovery and translation. PARTICIPANTS: Anthony S. Fauci, MD, Director, NIAID Michael G Kurilla, MD-PhD Director, Office of BioDefense Research Affairs Associate Director for BioDefense Product Development , NIAID DISCUSSION POINTS/TALKING POINTS (using concise/to the point bullets): Attachments: • Bios • Relevant correspondence • Supplemental Information • Etc. Thank you, Nicholas DiCrosta Management Intern currently on rotation with the NIH Executive Secretariat